AU Patent

AU2015360386B2 — Process for manufacturing phenylephrine resinate particles; phenylephrine resinate particles; and use of phenylephrine resinate particles in pharmaceutical formulations

Assigned to Kenvue Brands LLC · Expires 2021-02-25 · 5y expired

What this patent protects

Phenylephrine particles suitable for solid, semi solid or liquid dosage forms are disclosed.

USPTO Abstract

Phenylephrine particles suitable for solid, semi solid or liquid dosage forms are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number: AU2015360386B2
Jurisdiction: AU
Classification: —
Expires: 2021-02-25
Drug substance claim: No
Drug product claim: No
Assignee: Kenvue Brands LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.